Labetalol Hydrochloride
Overview
Labetalol Hydrochloride is a non-selective beta blocker with alpha-1 adrenergic receptor blocking activity used mainly in the treatment of high blood pressure. It mitigates hypertension by decreasing heart rate and reducing vascular resistance.
API suppliers (11)
Suppliers of Labetalol Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 9 of 11 suppliers.
7 of 11 hold a GMP certificate on record in the EU or UK registers
- PHLOW CORPUnited States1 active DMF
- CAMBREX PROFARMACO MILANO SRLItaly1 active DMF GMP on record
- COSMA SPAItaly1 active DMF GMP on record
- FLAMMA SPAItaly1 active DMF GMP on record
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
- OLON SPAItaly1 active DMF GMP on record
- GLAXOCHEM LTD
- SIBEFAT SPA
- ERREGIERRE SPAItaly GMP on record
- Teva Pharmaceutical Industries Ltd.Israel GMP on record
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain
EU CEP holders (5)
Companies holding a valid EU Certificate of Suitability (CEP) for Labetalol Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Labetalol Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.